1. Home
  2. FEIM vs CADL Comparison

FEIM vs CADL Comparison

Compare FEIM & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

HOLD

Current Price

$48.11

Market Cap

494.3M

Sector

Industrials

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$4.67

Market Cap

280.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEIM
CADL
Founded
1961
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.3M
280.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
FEIM
CADL
Price
$48.11
$4.67
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$42.50
$18.50
AVG Volume (30 Days)
149.6K
1.3M
Earning Date
06-15-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
316.95
58.62
EPS
0.25
N/A
Revenue
$69,811,000.00
$125,000.00
Revenue This Year
$5.52
N/A
Revenue Next Year
$17.07
N/A
P/E Ratio
$186.64
N/A
Revenue Growth
26.30
N/A
52 Week Low
$14.41
$4.25
52 Week High
$61.47
$9.08

Technical Indicators

Market Signals
Indicator
FEIM
CADL
Relative Strength Index (RSI) 44.26 36.72
Support Level $45.65 $4.57
Resistance Level $59.91 $6.16
Average True Range (ATR) 4.94 0.23
MACD -0.31 -0.01
Stochastic Oscillator 20.41 5.06

Price Performance

Historical Comparison
FEIM
CADL

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: